Zobrazeno 1 - 10
of 201
pro vyhledávání: '"J P, Boulenger"'
Autor:
D. Capdevielle, Laura Cif, Victoria Gonzalez, Philippe Coubes, P.-A. Hauseux, J.-P. Boulenger, Fabienne Cyprien
Publikováno v:
European Journal of Paediatric Neurology. 21:214-217
Objectives Tourette syndrome (TS) is a complex neuropsychiatric disorder associated with comorbid psychiatric disorders. Peak of tic severity typically occurs in early adolescence and impacts quality of life. Since 1999, promising therapeutic effects
Autor:
Jean-Frédéric Brun, J.-P. Boulenger, R. Raimondi, J. Attal, A. Hermes, D. Capdevielle, Ahmed Jérôme Romain
Publikováno v:
Science & Sports. 24:265-268
Resume Introduction Beaucoup de traitements psychotropes interferent avec la regulation ponderale et occasionnent une prise de poids. Nous avons voulu etudier l’effet d’un reentrainement en endurance ciblee au point d’oxydation maximale des lip
Autor:
J P Boulenger, D Capdevielle
Publikováno v:
EMC - Psychiatrie. 4:1-6
Autor:
M. Villiet, Jean-Marc Davy, A. Terminet, L Ayach, P Hemmi, P Rambourg, B Millat, A Blain, B. Combe, I Roch-Torreilles, B. Celton, Hubert Blain, R Thuret, Xavier Quantin, J. Ribstein, Georges Mourad, Jean Bousquet, Christian Geny, Isabelle Quéré, D Rosant, Rodolphe Bourret, Michael Bismuth, François Puisieux, M. Léglise, Florence Leclercq, N Deshormières, A. Le Quellec, Dominique Hillaire-Buys, A. Jalabert, Boris Jung, Eric Renard, P Biboulet, Yves Rolland, Olivier Jonquet, Groupe de travail Chu de Montpellier – Macvia-Lr, Jacques Morel, Y Dauvilliers, J –P Boulenger, MP Ponrouch
Publikováno v:
La Revue De Médecine Interne
La Revue De Médecine Interne, Elsevier, 2015, 36 (10), pp.677-689. ⟨10.1016/j.revmed.2015.03.016⟩
La Revue de Médecine Interne
La Revue de Médecine Interne, 2015, 36 (10), pp.677-689. ⟨10.1016/j.revmed.2015.03.016⟩
La Revue De Médecine Interne, Elsevier, 2015, 36 (10), pp.677-689. ⟨10.1016/j.revmed.2015.03.016⟩
La Revue de Médecine Interne
La Revue de Médecine Interne, 2015, 36 (10), pp.677-689. ⟨10.1016/j.revmed.2015.03.016⟩
Drug-induced adverse effects are one of the main avoidable causes of hospitalization in older people. Numerous lists of potentially inappropriate medications for older people have been published, as national and international guidelines for appropria
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a54bad52440160961feabfacbebad4b
https://hal.umontpellier.fr/hal-01770217/document
https://hal.umontpellier.fr/hal-01770217/document
Publikováno v:
Current Medical Research and Opinion. 22:1331-1341
This randomised, double-blind, fixed-dose study evaluated the efficacy of escitalopram and paroxetine in the long-term treatment of severely depressed patients with major depressive disorder (MDD).Patients with a primary diagnosis of MDD and baseline
Publikováno v:
European Journal of Neuroscience. 11:1470-1478
The central benzodiazepine receptor (cBZr) has long been implicated in anxiety disorders on the basis of: (i) the well-known anxiolytic and anxiogenic properties of cBZr agonists and inverse agonists, respectively; (ii) a possibly reduced sensitivity
Autor:
G, Fond, D, Capdevielle, A, Macgregor, J, Attal, A, Larue, M, Brittner, D, Ducasse, J-P, Boulenger
Publikováno v:
L'Encéphale
L'Encéphale, Elsevier Masson, 2012, epub ahead of print. ⟨10.1016/j.encep.2012.06.014⟩
L'Encéphale, Elsevier Masson, 2012, epub ahead of print. ⟨10.1016/j.encep.2012.06.014⟩
International audience; INTRODUCTION: Toxoplasma gondii is the most common protozoan parasite in developed nations. Up to 43% of the French population may be infected, depending on eating habits and exposure to cats, and almost one third of the world
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::e26bebb79d685a263abcf503cde4c933
https://www.hal.inserm.fr/inserm-00750381
https://www.hal.inserm.fr/inserm-00750381
Publikováno v:
L'Encephale. 39(5)
The DSM-IV and ICD-10 descriptions of adjustment disorders are broadly similar. Their main features are the following: the symptoms arise in response to a stressful event; the onset of symptoms is within 3 months (DSM-IV) or 1 month (ICD-10) of expos
Autor:
J, Del-Monte, D, Capdevielle, M-C, Gély-Nargeot, H, Yazbek, F, Pupier, J-P, Boulenger, S, Raffard
Publikováno v:
L'Encephale. 39
Schizophrenia is a chronic and severe mental illness that affects over 1% of the population, characterized by multiple symptom dimensions. One of this class of symptoms, "negative symptoms", have received more attention over the last few years. Negat